GOVX GeoVax Labs, Inc.
Healthcare$3.49-4.12%ClosedMarket Cap: $3.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
14.80
P/S
4.09
EV/EBITDA
-0.12
DCF Value
$2,339,802.99
FCF Yield
-545.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
102.5%
Operating Margin
-2523.4%
Net Margin
-2507.3%
ROE
-0.0%
ROA
-716.5%
ROIC
-2421.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-5.3M | $-5.3M | $— | — |
| Q4 null | $0.00 | Infinity% | $-4.4M | $-4.4M | $— | — |
| FY null | $2.5M | 100.0% | $-21.6M | $-21.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-6.4M | $-6.3M | $— | — |
| Q2 null | $852.3K | 100.0% | $-5.4M | $-5.4M | $— | — |
| Q1 null | $1.6M | 100.0% | $-5.4M | $-5.4M | $— | — |
| Q4 null | $864.4K | 97.5% | $-8.3M | $-8.3M | $— | — |
| FY null | $4.0M | 97.6% | $-25.1M | $-25.0M | $— | — |
| Q3 null | $2.8M | 100.0% | $-5.9M | $-5.8M | $— | — |
| Q2 null | $300.7K | 100.0% | $-5.1M | $-5.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-5.9M | $-5.9M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-7.7M | $-7.6M | $-74.75 | — |